 Atrial Fibrillation
"Atrial Fibrillation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Descriptor ID |
D001281
|
| MeSH Number(s) |
C14.280.067.198 C23.550.073.198
|
| Concept/Terms |
Atrial Fibrillation- Atrial Fibrillation
- Atrial Fibrillations
- Fibrillation, Atrial
- Fibrillations, Atrial
- Auricular Fibrillation
- Auricular Fibrillations
- Fibrillation, Auricular
- Fibrillations, Auricular
|
Below are MeSH descriptors whose meaning is more general than "Atrial Fibrillation".
Below are MeSH descriptors whose meaning is more specific than "Atrial Fibrillation".
This graph shows the total number of publications written about "Atrial Fibrillation" by people in UAMS Profiles by year, and whether "Atrial Fibrillation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2020 | 2 | 2 | 4 | | 2019 | 6 | 2 | 8 | | 2018 | 3 | 1 | 4 | | 2017 | 9 | 0 | 9 | | 2016 | 6 | 0 | 6 | | 2015 | 15 | 2 | 17 | | 2014 | 10 | 1 | 11 | | 2013 | 9 | 1 | 10 | | 2012 | 8 | 0 | 8 | | 2011 | 8 | 1 | 9 | | 2010 | 2 | 1 | 3 | | 2009 | 2 | 0 | 2 | | 2008 | 2 | 2 | 4 | | 2007 | 3 | 0 | 3 | | 2006 | 3 | 0 | 3 | | 2005 | 3 | 0 | 3 | | 2003 | 0 | 1 | 1 | | 2002 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 1999 | 0 | 1 | 1 | | 1998 | 1 | 0 | 1 | | 1997 | 0 | 1 | 1 | | 1994 | 1 | 0 | 1 | | 1990 | 0 | 1 | 1 | | 1988 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Atrial Fibrillation" by people in Profiles over the past ten years.
-
Yaghi S, Mistry E, Liberman AL, Giles J, Asad SD, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Lord A, Furie K, Keyrouz S, Nouh A, Leon Guerrero CR, de Havenon A, Khan M, Henninger N. Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study. Stroke. 2020 09; 51(9):2724-2732.
-
Yaghi S, Henninger N, Scher E, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Espaillat KB, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Liberman AL, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Trivedi T, Leon Guerrero CR, Khan M, Nouh A, Mistry E, Keyrouz S, Furie K. Early ischaemic and haemorrhagic complications after atrial fibrillation-related ischaemic stroke: analysis of the IAC study. J Neurol Neurosurg Psychiatry. 2020 07; 91(7):750-755.
-
Yaghi S, Liberman AL, Henninger N, Grory BM, Nouh A, Scher E, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Fakhri H, Espaillat KB, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Trivedi T, Ishida K, Frontera J, Lord A, Furie K, Keyrouz S, de Havenon A, Mistry E, Leon Guerrero CR, Khan M. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation. J Stroke Cerebrovasc Dis. 2020 Jul; 29(7):104888.
-
Faramawi MF, Delhey L, Abouelenein S, Delongchamp R. Metabolic syndrome and P-wave duration in the American population. Ann Epidemiol. 2020 06; 46:5-11.
-
Hanna B, Desai R, Kumar G, Sachdeva R. The authors reply. Crit Care Med. 2019 12; 47(12):e1032-e1033.
-
Kamran S, Akhtar N, George P, Singh R, Imam Y, Salam A, Babu B, Burke P, Own A, Vattoth S, Perkins J, Parray A, Qadri S, Hamid T. Embolic Pattern of Stroke Associated with Cardiac Wall Motion Abnormalities; Narrowing the Embolic Stroke of Undetermined Source Category. J Stroke Cerebrovasc Dis. 2020 Feb; 29(2):104509.
-
Desai R, Hanna B, Singh S, Omar A, Deshmukh A, Kumar G, Foreman MG, Sachdeva R. Trends and Outcomes in Sepsis Hospitalizations With and Without Atrial Fibrillation: A Nationwide Inpatient Analysis. Crit Care Med. 2019 08; 47(8):e630-e638.
-
Ayyaswami V, Padmanabhan DL, Crihalmeanu T, Thelmo F, Prabhu AV, Magnani JW. Mobile health applications for atrial fibrillation: A readability and quality assessment. Int J Cardiol. 2019 10 15; 293:288-293.
-
Reilly RF, Jain N. Warfarin in nonvalvular atrial fibrillation-Time for a change? Semin Dial. 2019 11; 32(6):520-526.
-
Kattoor AJ, Pothineni NV, Goel A, Syed M, Syed S, Paydak H, Mehta JL. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis. J Cardiovasc Pharmacol Ther. 2019 09; 24(5):428-434.
-
Rutlen C, Rutlen DL. Is Endurance Exercise Safe? The Myth of Pheidippides. South Med J. 2019 04; 112(4):210-214.
-
Yap J, Chia SY, Lim FY, Allen JC, Teo L, Sim D, Go YY, Jaufeerally FR, Seow M, Kwok B, Liew R, Lam CS, Ching CK. The Singapore Heart Failure Risk Score: Prediction of Survival in Southeast Asian Patients. Ann Acad Med Singap. 2019 Mar; 48(3):86-94.
-
Smer A, Salih M, Darrat YH, Saadi A, Guddeti R, Mahfood Haddad T, Kabach A, Ayan M, Saurav A, Abuissa H, Elayi CS. Meta-analysis of randomized controlled trials on atrial fibrillation ablation in patients with heart failure with reduced ejection fraction. Clin Cardiol. 2018 Nov; 41(11):1430-1438.
-
Goel A, Agnihotri K, Ashish K, Subramany S, Paydak H. Novel biomarkers for atrial fibrillation: A recent update. Int J Cardiol. 2019 02 15; 277:248.
-
Smer A, Salih M, Mahfood Haddad T, Guddeti R, Saadi A, Saurav A, Belbase R, Ayan M, Traina M, Alla V, Del Core M. Meta-analysis of Randomized Controlled Trials on Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Prevention of Cryptogenic Stroke. Am J Cardiol. 2018 06 01; 121(11):1393-1399.
-
Adelborg K, Szépligeti SK, Holland-Bill L, Ehrenstein V, Horváth-Puhó E, Henderson VW, Sørensen HT. Migraine and risk of cardiovascular diseases: Danish population based matched cohort study. BMJ. 2018 01 31; 360:k96.
-
Bunch TJ, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Jacobs V, Mallender C, Osborn JS, Weiss JP. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke. J Cardiovasc Electrophysiol. 2018 02; 29(2):221-226.
-
Go YY, Sugimoto T, Bulluck H, Acharyya S, Allen JC, Chia SY, Jaufeerally FR, Sim D, Lim TK, Liew R, Lam CSP. Age and ejection fraction modify the impact of atrial fibrillation on acute heart failure outcomes. Eur J Heart Fail. 2018 04; 20(4):821-822.
-
Khan MH, Rochlani Y, Aronow WS. Efficacy and safety of dronedarone in the treatment of patients with atrial fibrillation. Expert Opin Drug Saf. 2017 Dec; 16(12):1407-1412.
-
Agnihotri K, Pothineni NV, Charilaou P, Vaidya VR, Thakkar B, Goyal V, Kadavath S, Patel N, Badheka A, Noseworthy P, Kapa S, Friedman P, Gersh B, Paydak H, Deshmukh A. Impact of atrial fibrillation on outcomes with motor vehicle accidents. Int J Cardiol. 2018 Jan 01; 250:128-132.
-
Jacobs V, May HT, Bair TL, Crandall BG, Cutler DO MJ, Day JD, Mallender C, Osborn JS, Weiss JP, Bunch TJ. Long-term aspirin does not lower risk of stroke and increases bleeding risk in low-risk atrial fibrillation ablation patients. J Cardiovasc Electrophysiol. 2017 Nov; 28(11):1241-1246.
-
Salih M, Smer A, Charnigo R, Ayan M, Darrat YH, Traina M, Morales GX, DiBiase L, Natale A, Elayi CS. Colchicine for prevention of post-cardiac procedure atrial fibrillation: Meta-analysis of randomized controlled trials. Int J Cardiol. 2017 Sep 15; 243:258-262.
-
Sharma R, Oni OA, Gupta K, Sharma M, Sharma R, Singh V, Parashara D, Kamalakar S, Dawn B, Chen G, Ambrose JA, Barua RS. Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation. J Am Heart Assoc. 2017 May 09; 6(5).
-
Adedinsewo D, Xu J, Agasthi P, Oderinde A, Adekeye O, Sachdeva R, Rust G, Onwuanyi A. Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2017 May; 10(5):e004573.
-
Vallurupalli S, Shanbhag A, Mehta JL. Controversies in postoperative atrial fibrillation after noncardiothoracic surgery: clinical and research implications. Clin Cardiol. 2017 May; 40(5):329-332.
-
Howard G, Safford MM, Moy CS, Howard VJ, Kleindorfer DO, Unverzagt FW, Soliman EZ, Flaherty ML, McClure LA, Lackland DT, Wadley VG, Pulley L, Cushman M. Racial Differences in the Incidence of Cardiovascular Risk Factors in Older Black and White Adults. J Am Geriatr Soc. 2017 01; 65(1):83-90.
-
Thacker EL, Soliman EZ, Pulley L, Safford MM, Howard G, Howard VJ. Investigation of selection bias in the association of race with prevalent atrial fibrillation in a national cohort study: REasons for Geographic And Racial Differences in Stroke (REGARDS). Ann Epidemiol. 2016 08; 26(8):534-539.
-
Ayoub K, Nairooz R, Almomani A, Marji M, Paydak H, Maskoun W. Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis. J Stroke Cerebrovasc Dis. 2016 Sep; 25(9):2215-21.
-
Shah A, Shewale A, Hayes CJ, Martin BC. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients. Stroke. 2016 06; 47(6):1555-61.
-
Weiss JP, May HT, Bair TL, Crandall BG, Cutler MJ, Day JD, Osborn JS, Mallender C, Bunch TJ. A Comparison of Remote Magnetic Irrigated Tip Ablation versus Manual Catheter Irrigated Tip Catheter Ablation With and Without Force Sensing Feedback. J Cardiovasc Electrophysiol. 2016 Mar; 27 Suppl 1:S5-S10.
-
Sen P, Kundu A, Sardar P, Chatterjee S, Nairooz R, Amin H, Aronow WS. Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis. Am J Cardiovasc Drugs. 2016 Feb; 16(1):33-41.
-
O'Neal WT, Qureshi W, Judd SE, Glasser SP, Ghazi L, Pulley L, Howard VJ, Howard G, Soliman EZ. Perceived Stress and Atrial Fibrillation: The REasons for Geographic and Racial Differences in Stroke Study. Ann Behav Med. 2015 Dec; 49(6):802-8.
-
Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day JD. The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation. J Cardiovasc Electrophysiol. 2016 Feb; 27(2):141-6.
-
Mathur P, Paydak H, Thanendrarajan S, van Rhee F. Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions. Clin Lymphoma Myeloma Leuk. 2016 Feb; 16(2):70-5.
-
Shewale AR, Johnson JT, Li C, Nelsen D, Martin BC. Net Clinical Benefits of Guidelines and Decision Tool Recommendations for Oral Anticoagulant Use among Patients with Atrial Fibrillation. J Stroke Cerebrovasc Dis. 2015 Dec; 24(12):2845-53.
-
Nadkarni GN, Patel AA, Konstantinidis I, Mahajan A, Agarwal SK, Kamat S, Annapureddy N, Benjo A, Thakar CV. Dialysis Requiring Acute Kidney Injury in Acute Cerebrovascular Accident Hospitalizations. Stroke. 2015 Nov; 46(11):3226-31.
-
Deshmukh A, Pothineni NV, Patel N, Badheka A, Mulpuru SK, Paydak H, Noseworthy PA. Trends in hospitalizations of young patients with atrial fibrillation: A cause for concern? Int J Cardiol. 2016 Jan 15; 203:164-5.
-
Shah N, Rochlani Y, Pothineni NV, Paydak H. Burden of arrhythmias in patients with multiple myeloma. Int J Cardiol. 2016 Jan 15; 203:305-6.
-
Klinger RY, Thunberg CA, White WD, Fontes M, Waldron NH, Piccini JP, Hughes GC, Podgoreanu MV, Stafford-Smith M, Newman MF, Mathew JP. Intraoperative Magnesium Administration Does Not Reduce Postoperative Atrial Fibrillation After Cardiac Surgery. Anesth Analg. 2015 Oct; 121(4):861-7.
-
Nairooz R, Ayoub K, Sardar P, Payne J, Almomani A, Pothineni NV, Shailesh F, Aronow WS, Mukherjee D. Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis. Can J Cardiol. 2016 06; 32(6):814-23.
-
Sheikh A, Patel NJ, Nalluri N, Agnihotri K, Spagnola J, Patel A, Asti D, Kanotra R, Khan H, Savani C, Arora S, Patel N, Thakkar B, Patel N, Pau D, Badheka AO, Deshmukh A, Kowalski M, Viles-Gonzalez J, Paydak H. Trends in hospitalization for atrial fibrillation: epidemiology, cost, and implications for the future. Prog Cardiovasc Dis. 2015 Sep-Oct; 58(2):105-16.
-
Bunch TJ, Day JD. Adverse Remodeling of the Left Atrium in Patients with Atrial Fibrillation: When Is the Tipping Point in Which Structural Changes Become Permanent? J Cardiovasc Electrophysiol. 2015 Jun; 26(6):606-7.
-
Yaghi S, Hinduja A, Bianchi N. Predictors of major improvement after intravenous thrombolysis in acute ischemic stroke. Int J Neurosci. 2016; 126(1):67-9.
-
Nairooz R, Sardar P, Payne J, Aronow WS, Paydak H. Meta-analysis of major bleeding with uninterrupted warfarin compared to interrupted warfarin and heparin bridging in ablation of atrial fibrillation. Int J Cardiol. 2015; 187:426-9.
-
Nairooz R, Sardar P, Pino M, Aronow WS, Sewani A, Mukherjee D, Paydak H, Maskoun W. Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation. Int J Cardiol. 2015; 187:345-53.
-
Kanmanthareddy A, Vallakati A, Reddy Yeruva M, Dixit S, DI Biase L, Mansour M, Boolani H, Gunda S, Bunch TJ, Day JD, Ruskin JN, Buddam A, Koripalli S, Bommana S, Natale A, Lakkireddy D. Pulmonary vein isolation for atrial fibrillation in the postpneumonectomy population: a feasibility, safety, and outcomes study. J Cardiovasc Electrophysiol. 2015 Apr; 26(4):385-389.
-
Bunch TJ, May HT, Bair TL, Jacobs V, Crandall BG, Cutler M, Weiss JP, Mallender C, Osborn JS, Anderson JL, Day JD. Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2015 Apr; 26(4):363-370.
-
Garimella RS, Chung EH, Mounsey JP, Schwartz JD, Pursell I, Gehi AK. Accuracy of patient perception of their prevailing rhythm: a comparative analysis of monitor data and questionnaire responses in patients with atrial fibrillation. Heart Rhythm. 2015 Apr; 12(4):658-65.
-
Pinto C, Samuel BP, Ratnasamy C, Vettukattil JJ. Thrombosis in Fontan patient on apixaban. Int J Cardiol. 2015 Mar 01; 182:66-7.
-
Ayoub K, Darouian N, Hayes K, Paydak H. A mysterious wide complex tachycardia. Acta Cardiol. 2014 Dec; 69(6):699.
-
Hammond DA, Smotherman C, Jankowski CA, Tan S, Osian O, Kraemer D, DeLosSantos M. Short-course of ranolazine prevents postoperative atrial fibrillation following coronary artery bypass grafting and valve surgeries. Clin Res Cardiol. 2015 May; 104(5):410-7.
-
Miller JM, Kowal RC, Swarup V, Daubert JP, Daoud EG, Day JD, Ellenbogen KA, Hummel JD, Baykaner T, Krummen DE, Narayan SM, Reddy VY, Shivkumar K, Steinberg JS, Wheelan KR. Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol. 2014 Sep; 25(9):921-929.
-
Badheka AO, Patel NJ, Grover PM, Shah N, Patel N, Singh V, Deshmukh AJ, Mehta K, Chothani A, Savani GT, Arora S, Rathod A, Marzouka GR, Lafferty J, Mehta JL, Mitrani RD. Optimal blood pressure in patients with atrial fibrillation (from the AFFIRM Trial). Am J Cardiol. 2014 Sep 01; 114(5):727-36.
-
O'Connor JM, Helmer SD, Khandelwal A. Atrial fibrillation in elderly burn patients. Am Surg. 2014 Jun; 80(6):623-4.
-
Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, Shah N, Chothani A, Savani GT, Mehta K, Parikh V, Rathod A, Badheka AO, Lafferty J, Kowalski M, Mehta JL, Mitrani RD, Viles-Gonzalez JF, Paydak H. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation. 2014 Jun 10; 129(23):2371-9.
-
Pothineni NV, Deshmukh A, Pant S, Patel NJ, Badheka A, Chothani A, Shah N, Mehta K, Savani GT, Singh V, Grover P, Bhalara V, Patel N, Arora S, Rathod A, Viles-Gonzalez J, Paydak H. Complication rates of atrial fibrillation ablations: comparison of safety outcomes from real world to contemporary randomized control trials. Int J Cardiol. 2014 Aug 01; 175(2):372-3.
-
Bunch TJ, Day JD. The electrophysiologist's new clothes and the cardiac MRI that told the truth. J Cardiovasc Electrophysiol. 2014 May; 25(5):464-465.
-
Patel N, Chung EH, Mounsey JP, Schwartz JD, Pursell I, Gehi AK. Effectiveness of atrial fibrillation monitor characteristics to predict severity of symptoms of atrial fibrillation. Am J Cardiol. 2014 May 15; 113(10):1674-8.
-
Sardar P, Nairooz R, Chatterjee S, Wetterslev J, Ghosh J, Aronow WS. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation. Am J Cardiol. 2014 Apr 01; 113(7):1173-7.
-
Bunch TJ, Weiss JP, Crandall BG, Day JD, May HT, Bair TL, Osborn JS, Mallender C, Fischer A, Brunner KJ, Mahapatra S. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Heart Rhythm. 2014 Apr; 11(4):533-40.
-
Thompson TS, Barksdale DJ, Sears SF, Mounsey JP, Pursell I, Gehi AK. The effect of anxiety and depression on symptoms attributed to atrial fibrillation. Pacing Clin Electrophysiol. 2014 Apr; 37(4):439-46.
-
Turagam MK, Addepally NS, Velagapudi P. Novel anticoagulants for stroke prevention in atrial fibrillation and chronic kidney disease. Expert Rev Cardiovasc Ther. 2013 Oct; 11(10):1297-9.
-
Deshmukh A, Patel NJ, Pant S, Shah N, Chothani A, Mehta K, Grover P, Singh V, Vallurupalli S, Savani GT, Badheka A, Tuliani T, Dabhadkar K, Dibu G, Reddy YM, Sewani A, Kowalski M, Mitrani R, Paydak H, Viles-Gonzalez JF. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 2013 Nov 05; 128(19):2104-12.
-
Cilingiroglu M, Cilingiroglu M, Marmagkiolis K, Marmagiolis K. Left atrial appendage closure: does "leak" matter? Catheter Cardiovasc Interv. 2013 Aug 01; 82(2):320.
-
Bamimore A, Mounsey JP. RE-LYing on dabigatran for periprocedural anticoagulation: is it safe? Pacing Clin Electrophysiol. 2013 Nov; 36(11):1325-7.
-
Casciano JP, Dotiwala ZJ, Martin BC, Kwong WJ. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective. J Manag Care Pharm. 2013 May; 19(4):302-16.
-
Deshmukh AJ, Pant S, Kumar G, Hayes K, Badheka AO, Dabhadkar KC, Paydak H. Seasonal variations in atrial fibrillation related hospitalizations. Int J Cardiol. 2013 Sep 30; 168(2):1555-6.
-
Plitt DC, Chung EH, Mounsey JP, Schwartz JD, Pursell IW, Gehi AK. Relation of atrial fibrillation burden and N-terminal pro-brain natriuretic peptide. Am J Cardiol. 2013 May 01; 111(9):1315-8.
-
Bunch TJ, Day JD. The atrial fibrillation ablation theory of relativity. J Cardiovasc Electrophysiol. 2013 Mar; 24(3):267-8.
-
Kumar P, Mounsey JP. Early recurrences are not always benign after catheter ablation of atrial fibrillation:do we need to reassess the need for a blanking period? J Cardiovasc Electrophysiol. 2012 Dec; 23(12):1302-3.
-
Rommel J, Simpson R, Mounsey JP, Chung E, Schwartz J, Pursell I, Gehi A. Effect of body mass index, physical activity, depression, and educational attainment on high-sensitivity C-reactive protein in patients with atrial fibrillation. Am J Cardiol. 2013 Jan 15; 111(2):208-12.
-
Bunch TJ, May HT, Crandall BG, Weiss JP, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Johnson DL, Day JD. Intracardiac ultrasound for esophageal anatomic assessment and localization during left atrial ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2013 Jan; 24(1):33-9.
-
Sureddi RK, Amani F, Hebbar P, Williams DK, Leonardi M, Paydak H, Mehta JL. Atrial fibrillation following autologous stem cell transplantation in patients with multiple myeloma: incidence and risk factors. Ther Adv Cardiovasc Dis. 2012 Dec; 6(6):229-36.
-
Schonberger M, Usman A, Galizia M, Popescu A, Collins J, Carr JC. Time-resolved MR venography of the pulmonary veins precatheter-based ablation for atrial fibrillation. J Magn Reson Imaging. 2013 Jan; 37(1):127-37.
-
Deshmukh A, Pant S, Kumar G, Badheka AO, Paydak H. Impact of obesity on atrial fibrillation hospitalization. Int J Cardiol. 2012 Sep 06; 159(3):241-2.
-
Deshmukh A, Pant S, Kumar G, Bursac Z, Paydak H, Mehta JL. Comparison of outcomes of weekend versus weekday admissions for atrial fibrillation. Am J Cardiol. 2012 Jul 15; 110(2):208-11.
-
Golden K, Mounsey JP, Chung E, Roomiani P, Morse MA, Patel A, Gehi A. Atrial fibrillation ablation using a closed irrigation radiofrequency ablation catheter. Pacing Clin Electrophysiol. 2012 May; 35(5):506-16.
-
Kashyap A, Li C. Trends in utilization of management strategies for newly diagnosed atrial fibrillation patients in the United States: 1999 to 2008. J Pharm Pract. 2012 Apr; 25(2):151-9.
-
Cilingiroglu M, Gupta A. The laa occlusion paradigm: are we there yet? Catheter Cardiovasc Interv. 2011 Nov 15; 78(6):974-5.
-
Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department. Ann Pharmacother. 2011 Jul; 45(7-8):881-7.
-
Bunch TJ, Day JD. Achieving favorable very long-term outcomes after catheter ablation for atrial fibrillation: an exciting adventure or delusional quest? J Cardiovasc Electrophysiol. 2011 Nov; 22(11):1215-6.
-
Mahapatra S, LaPar DJ, Kamath S, Payne J, Bilchick KC, Mangrum JM, Ailawadi G. Initial experience of sequential surgical epicardial-catheter endocardial ablation for persistent and long-standing persistent atrial fibrillation with long-term follow-up. Ann Thorac Surg. 2011 Jun; 91(6):1890-8.
-
Bunch TJ, Crandall BG, Weiss JP, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, Day JD. Patients treated with catheter ablation for atrial fibrillation have long-term rates of death, stroke, and dementia similar to patients without atrial fibrillation. J Cardiovasc Electrophysiol. 2011 Aug; 22(8):839-45.
-
Virani SS, Brautbar A, Lee VV, Elayda M, Sami S, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM. Usefulness of single nucleotide polymorphism in chromosome 4q25 to predict in-hospital and long-term development of atrial fibrillation and survival in patients undergoing coronary artery bypass grafting. Am J Cardiol. 2011 May 15; 107(10):1504-9.
-
Malasana G, Day JD, Weiss JP, Crandall BG, Bair TL, May HT, Osborn JS, Anderson JL, Muhlestein JB, Lappe DL, Nelson J, Bunch TJ. A strategy of rapid cardioversion minimizes the significance of early recurrent atrial tachyarrhythmias after ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2011 Jul; 22(7):761-6.
-
Singla S, Karam P, Deshmukh AJ, Mehta J, Paydak H. Review of contemporary antiarrhythmic drug therapy for maintenance of sinus rhythm in atrial fibrillation. J Cardiovasc Pharmacol Ther. 2012 Mar; 17(1):12-20.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|